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Abstract
Summary We conducted a cluster randomized trial
evaluating the effect of a centralized coordinator who
identifies and follows up with fracture patients and their
primary care physicians about osteoporosis. Compared
with controls, intervention patients were five times more
likely to receive BMD testing and two times more likely
to receive appropriate management.
Introduction To determine if a centralized coordinator who
follows up with fracture patients and their primary care
physicians by telephone and mail (intervention) will
increase the proportion of patients who receive appropri-
ate post-fracture osteoporosis management, compared to
simple fall prevention advice (attention control).
Methods A cluster randomized controlled trial was
conducted in small community hospitals in the province
of Ontario, Canada. Hospitals that treated between 60
and 340 fracture patients per year were eligible. Patients
40 years and older presenting with a low trauma
fracture were identified from Emergency Department
records and enrolled in the trial. The primary outcome
was ‘appropriate’ management, defined as a normal
bone mineral density (BMD) test or taking osteoporosis
medications.
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DOI 10.1007/s00198-011-1726-7Results Thirty-six hospitals were randomized to either
intervention or control and 130 intervention and 137
control subjects completed the study. The mean age of
participants was 65±12 years and 69% were female. The
intervention increased the proportion of patients who
received appropriate management within 6 months of
fracture; 45% in the intervention group compared with
26% in the control group (absolute difference of 19%;
adjusted OR, 2.3; 95% CI, 1.3–4.1). The proportion who
had a BMD test scheduled or performed was much higher
with 57% of intervention patients compared with 21% of
controls (absolute difference of 36%; adjusted OR, 4.8;
95% CI, 3.0–7.0).
Conclusions A centralized osteoporosis coordinator is
effective in improving the quality of osteoporosis care in
smaller communities that do not have on-site coordinators
or direct access to osteoporosis specialists.
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Introduction
Prevention of osteoporotic fractures depends on the
identification of individuals at risk for fractures, followed
by interventions to reduce this risk, such as modification of
lifestyle factors and use of bone-sparing medications [1, 2].
The presence of a low trauma fracture is a significant risk
factor for predicting future fracture; about 50% of those that
survive experience a subsequent fracture in 10 years [3].
Clinical practice guidelines state that a low trauma fracture
should signal the opportunity to initiate osteoporosis
treatment for prevention of subsequent fractures [1, 2].
Two systematic reviews concluded that despite the
availability of effective treatment options, the majority of
patients who experience a low trauma fracture are under-
investigated and under-treated for osteoporosis, within
Canada and internationally [4, 5]. This highlights an
important care gap [6]. In Europe and North America, the
care gap has resulted in action plans to improve bone health
[7–10]. One such plan, currently being implemented, is the
Ontario Osteoporosis Strategy, a population-based chronic
disease management program [10]. The overall goal is to
reduce morbidity, mortality and costs from osteoporosis and
related fractures by raising public awareness, changing
knowledge, attitudes and behaviours of both the public
and health professionals and improving prevention and
treatment programs.
Secondary fracture prevention is a major focus with a
province-wide Fracture Clinic Screening Program imple-
mented in 36 medium- and high-volume fracture clinics.
Based on the Osteoporosis Exemplary Care Program
developed by Bogoch et al. [11], Screening Coordinators
conduct an osteoporosis assessment, provide education,
refer low trauma fracture patients to their primary care
physician for follow-up and send a letter recommending
that the patient be assessed for osteoporosis with bone
mineral density (BMD) testing. Unfortunately, by restricting
the Osteoporosis Strategy coordinators to medium and large
volume hospitals with fracture clinics, the program misses
about one third of fracture patients in Ontario who are
treated in small community hospitals as funding an
osteoporosis coordinator is not justifiable in each small
community hospital. Yet, similar to others [12, 13], we have
previously shown that an educational intervention alone
was not sufficient to improve practice [14], suggesting the
need for a more targeted intervention in smaller communi-
ties. There have been a number of recent randomized
controlled trials of post-fracture care interventions that have
reported positive effects [15–23] with a pooled absolute
improvement in osteoporosis treatment rates of 20% over
and above usual care [24]. However, in all of these trials the
majority of patients were recruited from academic centres
or health maintenance organizations with high fracture
volumes and access to osteoporosis specialists.
The current cluster randomized trial was conducted to
determine if an intervention based on the osteoporosis
coordinator role in the focused environment of a high-
volume urban fracture clinic can be effective when adapted
to smaller community hospitals. We hypothesized that a
centralized coordinator who identifies and follows up with
fracturepatientsandtheirprimarycarephysiciansbytelephone
and mail will increase the proportion of patients who receive
appropriate investigation and treatment for osteoporosis
compared with simple fall prevention advice among patients.
Methods
Study design
We conducted a cluster randomized trial in which the
hospital emergency department was the unit (cluster) of
allocation and men and women with a low trauma fracture
were the unit of analysis. Since the purpose of the trial was
to change practice behaviour and patients in these commu-
nities were likely to have the same primary care physician,
a cluster design was chosen to minimize contamination.
Setting and participants
Hospital eligibility criteria and recruitment
Hospitals without a dedicated osteoporosis screening
coordinator that treated more than 60 fracture patients
88 Osteoporos Int (2012) 23:87–95per year in their Emergency Department (ED) and who
were members of the Ontario Telemedicine Network
were potentially eligible (n=54). Information letters were
sent to the hospitals explaining the study and site visits
were conducted by the centralized coordinator. Ethics
approval was obtained from the Research Ethics Board of
the Toronto Rehabilitation Institute and each of the
participating sites.
Patient eligibility criteria and recruitment
Emergency Department records provided through the
National Ambulatory Care Reporting System database at
each hospital site were used to identify all new cases of
fracture. Records of patients 40 years and older presenting
with a fracture of the hip, forearm, wrist, rib(s), sternum,
thoracic and lumbar spine, shoulder and upper arm, pelvis,
lower leg and ankle were identified. Patients with ‘cause of
injury’ codes indicating the fracture was not likely due to a
fall from a standing height (e.g. transportation accidents or
other major trauma), who were residing in a nursing home,
or with fractures that occurred more than 3 months between
the time of their initial ED visit and preparation of the list
for the centralized coordinator were excluded. On a
monthly basis, a list of fracture patients was provided to
the centralized coordinator. Participants were recruited by
telephone between January and July 2008 and further
screened with the following exclusion criteria: unable to
contact, died, in long-term care, cognitive or hearing
impairment, lived outside of region and previously screened
by an Osteoporosis Strategy coordinator at another hospital.
Intervention
The multi-faceted intervention was comprised of having the
centralized coordinator, a physical therapist, follow-up with
fracture patients and their physicians to provide evidenced-
based recommendations about fracture risk and osteoporo-
sis treatment and assist with arranging telehealth consulta-
tions to the Multidisciplinary Osteoporosis Program (MOP)
[25] at a teaching hospital for complex patients if requested.
Patient component
In the intervention arm, the centralized coordinator phoned
fracture patients and counselled them about their risk of
osteoporosis, the need to follow-up with their primary care
physician to discuss osteoporosis and the need for a BMD
test and provided information about existing resources for
osteoporosis management. A standard baseline question-
naire was completed, and consent was obtained for the
research assistant to contact them and collect follow-up
data. Each patient was sent a personalized letter reiterating
the conversation. Three months later, they received a
reminder phone call from the coordinator and were
encouraged to follow-up with their primary care physician
if they had not already done so. At 6 months, patients
completed a follow-up questionnaire administered by the
research assistant who was blinded to treatment allocation.
Physician component
The centralized coordinator sent the patient’s primary care
physician a letter informing them that their patient had
experienced a fracture. The letter was tailored for each patient
and highlighted: (1) the patient’s high risk for osteoporosis
and need for a BMD test if one has not been done in the past
6 months, (2) high 1-year fracture risk in the presence of
fracture and BMD T-score is≤1.5 if the patient goes untreated
[26], (3) efficacy of first-line treatment with bisphosphonates
on fracture risk, and (4) availability of osteoporosis specialist
consultation through the MOP if desired. Physicians were
asked to place the letter in the patient’s office chart as a
point-of-care reminder for the next visit. Primary care
physicians also received pocket cards containing evidence-
based recommendations about appropriate BMD testing and
treatment based on the most recent Canadian guidelines
available at the time of the trial [1, 27].
Attention controls
Similartotheinterventionhospitals,within3monthsoftheED
visit for fracture, patients from the control hospitals received
educational material and telephone counseling regarding fall
prevention and home safety from the centralized coordinator.
Patients were encouraged to visit their primary care physician
foramoredetailedadviceandmedicationreview.Theydidnot
receivecounselingoreducationalmaterialsaboutosteoporosis.
The coordinator administered the baseline questionnaire and
obtained consent for the research assistant to collect follow-up
data at 6 months. The control group did not receive the 3-
month reminder phone call.
Outcomes and measurements
The primary outcome was the proportion of patients self-
reporting ‘appropriate management’, defined as receiving,
within 6 months of fracture, either an osteoporosis
medication (bisphosphonate, raloxifene or teriparatide) or
normal BMD and prevention advice. Previous research has
shown excellent agreement between self-report and dis-
pensing records for osteoporosis medications [28, 29] and
self-report for having had a BMD test [30]. This composite
outcome was chosen because unlike the other post-fracture
care trials that excluded patients already taking osteoporosis
medications [15–23], this trial included patients who were
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enced a low trauma fracture. The Canadian guidelines
recommended that these patients should have their BMD
reassessed and medications reviewed [1, 27]. Secondary
outcomes were: the proportion of patients with a physician
visit to discuss osteoporosis after fracture, and the propor-
tion for which BMD was scheduled or performed.
Sample size
The sample size was based on a binary outcome
(appropriate management—yes/no). In a survey of oste-
oporosis researchers and clinicians from Canada and the
USA, the median response reported for a ‘minimal
clinically important difference’ for a post-fracture care
intervention was 20% over and above ‘usual care’ [31].
From our demonstration project in five small communities
in Ontario [14], we found that 31% of patients had a BMD
test after fracture. We anticipated a cluster size of ten
patients per hospital and an intra-cluster correlation
coefficient of 0.01 [32]. Therefore, we needed to identify
about 20 fracture patients in each of 30 hospitals to detect
an effect size of 20% (intervention=50% and controls=
30%) with 90% power. Therefore, the final sample was at
least 300 patients (ten patients per cluster with 15
intervention and 15 control clusters). The level of
statistical significance was set at p<0.05.
Randomization
Hospitals that agreed to participate were assigned by simple
random allocation to invention or attention control. Ran-
domization was performed with a computer program by the
statistician who was blind to the hospitals’ identity. The
investigators and the research assistant collecting the
outcome information were blinded to treatment allocation
Statistical analyses
To assess the quality of randomization, demographic and
clinical characteristics in the intervention and control groups
were calculated using descriptive statistics. To assess for
differences between outcomes in the intervention and control
groups, multi-level hierarchical modelling using the General
Estimating Equation (GEE) approach was used to account for
clustering to estimate the treatment effect as an odds ratio and
test for significance [33, 34]. First-order interaction terms
(specifically: sex by intervention status) were evaluated. The
95% confidence intervals and p values were calculated using
the sandwich estimator of variance. The analysis was carried
out using R: A Language and Environment for Statistical
Computing version 2.10.1 [35, 36]. The GEE models were
fit using the R package geepack version 1.0-17.
Results
Study flow
Of the 54 eligible hospitals, 36 agreed to participate and were
randomly assigned to intervention or control group (18 in
each group). We obtained 801 records for fracture patients
within 3 months of their admission to the ED; 139 were
received3monthsafter fracture.Ofthese,443wereexcluded:
298 were unable to reach, 51 had died or were in long-term
care, 43 lived outside of the hospital catchment area, 21
refused, 18 had previously been screened by a fracture clinic
coordinator and 12 had significant cognitive or hearing
impairment, resulting in 358 enrolled subjects (Fig. 1).
Cluster size was comparable between the groups with ten
(range, 3–16) in the intervention and ten (range, 4–18) in the
control hospitals. Of those randomized, 52 from the interven-
tion hospitals and 39 from the control hospitals were lost to
follow-up leaving a total of 267 subjects with complete data
for analysis. The primary analysis is a ‘complete case’ and
includes only those whose outcome is known [37]. A
secondary analysis was the strict intention to treat analysis
in which all randomized subjects were included.
Baseline characteristics
The mean age of the study participants was 66.0 years in
the intervention and 65.4 in the control group; about two
thirds were female and married. Twenty-seven percent had a
history of a previous fracture since the age of 40 years, 20%
were current smokers and 23% had fallen in the previous
12 months. Thirty-one percent had a BMD test in the
previous 12 months, 25% self-reported a diagnosis of
osteoporosis and 19% were currently taking osteoporosis
medications. The most common fracture type was wrist
(34%), followed by ankle (16%), rib (12%), shoulder (12%)
and hip (8%). There was no significant difference in
demographic and clinical characteristics among patients in
the intervention and control groups (Table 1).
Outcomes
The intervention increased the proportion of patients who
received appropriate management, defined as taking an
osteoporosis medication or normal BMD and prevention
advice within 6 months of fracture: 45% (59/130) in the
intervention group compared with 26% (35/137) in the
control group, giving an absolute difference of 20%;
cluster-adjusted OR, 2.3; 95% CI, 1.3–4.1; p=0.003
(Table 2). Of the 45% in the intervention group appropri-
ately managed, 23% had normal BMD and 22% were on
treatment and of the 26% in the control group, 9% had
normal BMD and 17% were on treatment. The proportion
90 Osteoporos Int (2012) 23:87–95who had a BMD test scheduled or performed was much
higher (57% of intervention patients compared with 21% of
controls; cluster-adjusted OR, 4.8; 95% CI, 3.0–7.0; p<
0.0001). The intervention resulted in the majority of
patients having a discussion about osteoporosis with their
physician: 82.2% intervention compared with 55.4%
control patients; cluster-adjusted OR, 3.8; 95% CI, 2.3–
6.3; p<0.0001. For the strict intention to treat analysis in
which all randomized subjects are included, the
corresponding proportions for appropriate management are
32% (59/182) in the intervention and 20% (35/176) in the
control, p=0.007.
Male and female differences
For each of the three outcomes in the hierarchical
modelling a test for an intervention by sex interaction was
not statistically significant. Of the 267 study participants
with outcome data, 29% were male. When analyses were
restricted to the intervention group, only 29% of males
compared with 51% of females were appropriately man-
aged (Table 3) while the proportions that had a BMD test
scheduled or performed (50% males compared with 59%
females) and that saw their primary care physician (76%
males and 84% females) were similar.
Discussion
This cluster randomized trial in 36 small community
hospitals with 267 study participants who suffered a low
trauma fracture found that the multi-faceted intervention
resulted in a significant increase in the proportion of
patients appropriately managed within 6 months of fracture
Assessed for eligibility 
(54 hospitals) 
Excluded: 
Refused to participate (18 hospitals) 
Randomized (36 hospital 
Emergency Departments (ED)) 
N = 801 
Excluded Patients: (n = 422, 53%) 
298 (37%) unable to reach 
51 (6%) died or long-term care 
43 (5%) lived outside region 
21 (2%) refused 
18 (2%) screened by other OP coordinator 
12 (1%) cognitive/hearing impairment 
Allocated to control: 18 EDs 
Received allocated intervention 
18 EDs, average cluster size= 9.8, 
range 4-18 
176 participants 
Allocated to intervention: 18 EDs 
Received allocated intervention 
18 EDs, average cluster size= 10.1, 
range 3-16 
182 participants 
Loss to Follow Up 
0 EDs, 52 participants 
2 admitted to long-term care 
22 withdrew 
28 did not complete follow up 
questionnaire 
Loss to Follow Up 
0 EDs, 39 participants 
4 admitted to long-term care 
23 withdrew 
12 did not complete follow up 
questionnaire
Clusters: 
Analysed 
18 EDs, average size = 7.2, range 3-12 
Participants: 
130 (71%) participants analysed 
Clusters: 
Analysed 
18 EDs, average size = 7.7, range 
3-14 
Participants: 
137 (78%) participants analysed
Fig. 1 Flow of patients through
the trial
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group, about a 20% absolute difference. The intervention
also resulted in more patients having a BMD scheduled or
performed and most having a discussion about osteoporosis
with their primary care physician compared to patients in
the control group.
To our knowledge, this is the first and only randomized
trial that has been restricted to patients from small or rural
communities. To date, there have been nine published post-
fracture care randomized controlled trials [24] that have
evaluated various interventions to improve management of
osteoporosis in this high-risk population. Two of these were
cluster randomized trials [19, 20], one in a health
maintenance organization with a large number of primary
care practices [16], three in one or two hospitals [17, 21,
23] and four in-patient interventions for those with hip
Table 2 Primary and secondary outcomes 6 months post-fracture
Outcome Intervention
(N=130 (%))
Control
(N=137 (%))
Intra-cluster correlation
coefficient
Adjusted odds
a ratio
(95% CI)
P value
Physician discussed osteoporosis 82.2 55.4 −0.012 3.8 (2.3–6.3) <0.001
BMD test 57.4 21.3 −0.026 4.8 (3.0–7.9) <0.001
Appropriate management 45.4 25.9 0.009 2.3 (1.3–4.1) 0.003
aAdjusted for age and sex
Characteristic N Intervention (n=130;
mean (SD) or (%))
Control (n=137;
mean (SD) or (%))
Demographic characteristics
Age in years 267 66.0 (11.0) 65.4 (11.6)
Female 267 96 (74%) 93 (68%)
College/university education 265 50 (39%) 58 (42%)
Married 266 84 (65%) 93 (68%)
Living alone 259 28 (23%) 35 (26%)
Employed full-time 266 32 (24%) 44 (32%)
Clinical characteristics
Prior fracture since age 40 266 36 (28%) 36 (26%)
Maternal history of hip fracture 267 11 (8%) 8 (6%)
Current smoker 266 25 (19%) 27 (20%)
Current weight (lbs—mean (SD)) 265 166.2 (33.2) 162.5 (34.7)
History of falls in past 12 months 266 29 (22%) 33 (24%)
Have trouble getting out of chair or
unsteady when walking
267 23 (18%) 22 (16%)
Oral steroid use for >3 months 265 11 (8%) 4 (3%)
Rheumatoid arthritis 265 4 (3%) 2 (1%)
More than 2 alcoholic drinks daily 263 5 (4%) 0 (0%)
Osteoporosis diagnosis 265 31 (24%) 36 (27%)
Currently taking osteoporosis medications 267 25 (19%) 26 (19%)
Bone mineral density test in past 12 months 265 38 (29%) 44 (32%)
Fracture type 267
Wrist 48 (37%) 44 (32%)
Ankle 16 (12%) 26 (19%)
Rib 16 (12%) 15 (11%)
Shoulder 15 (11%) 15 (11%)
Hip 12 (9%) 9 (6%)
Tibia/fibula 7 (5%) 13 (9%)
Humerus 5 (4%) 3 (2%)
Spine 2 (1%) 2 (1%)
Pelvis 3 (2%) 1 (1%)
Table 1 Baseline demographic
and clinical characteristics,
N=267
92 Osteoporos Int (2012) 23:87–95fracture [15, 17, 18, 22]. The pooled absolute improve-
ments across these nine trials in BMD testing was 36% and
for osteoporosis treatment 20% (95% CI, 10–30) which is
virtually identical to what we observed in terms of our pre-
defined outcome of appropriate osteoporosis management.
The interventions vary in many of the nine prior
randomized trials, ranging from point-of-care reminders to
physicians to patient-specific education. This is reflected in
the heterogeneity seen when trying to pool results (e.g. an
I2 of 88% for improvements in osteoporosis treatment)
[24]. In the study by Feldstein et al. [16], the intervention
was an electronic medical record reminder which resulted
in 52% of intervention patients getting a BMD test or
osteoporosis medication at 6 months compared with 6% of
the usual care. Whereas, in the study by Majumdar et al.
[21], the intervention was multi-faceted with telephone-
based nurse led education, a patient-specific reminder sent
to the physician and guidelines endorsed by local opinion
leaders. These findings with 22% of intervention and 7% of
control patients on treatment with a bisphosphonate 6 months
after a wrist fracture are similar to those reported by Cranney
et al. [20] who only used mailed reminders to patients and
primary care physicians and a patient education package.
Rozenthal et al. [23] randomized 50 distal radius fracture
patients to either the orthopaedic surgeon ordering a BMD
test and forwarding the results to the primary care physician
or just sending a letter to the primary care physician
outlining guidelines for osteoporosis screening. Initiation of
osteoporosis therapy was much higher (74%) than in other
studies but this trial did not only consider treatment with
bisphosphonates but also counted initiation with calcium and
vitamin D as a treatment outcome.
We believe the key factor to the success of our
intervention was that the coordinator empowered the patient
to ask for a BMD test and made the patient the ‘reminder’
for the physician. This particular combination of a multi-
faceted intervention, where you have a triad of a coordina-
tor, patient and primary care physician, should be evaluated
as a model for improving guideline adherence for other
chronic diseases, particularly among physicians in smaller
communities with limited access to specialist care.
One of the advantages of the current trial is the ability to
examine sex differences in post-fracture osteoporosis manage-
ment. Previous research has shown that the care gap is
significant in both men and women but more so in men [38,
39]. Our study has shown that care improved for both;
however, there are still substantially greater care gaps in men
versus women, as others have shown despite interventions;
possible reasons are men and their physicians view osteopo-
r o s i sa sad i s e a s eo fe l d e r l yw o m e n[ 40, 41]a n dm o r e
importantly, guidelines are unclear about treatment options. In
the new 2010 Canadian guidelines, there is grade A evidence
for investigating men with a fracture but grade D evidence for
prescribing bisphosphonate therapy in men [42].
This study had a number of strengths. This was a
randomized trial with a cluster design which minimized
contamination because hospital sites rather than individual
patients were randomized. The cluster design also increases
the generalizability of the findings since the study was
carried out in a large number of hospitals. This is the only
randomized trial published to date of a post-fracture care
intervention in rural communities without access to osteo-
porosis specialists and in many cases orthopaedic surgeons.
One of the limitations of this study is the potential for
selection bias as were unable to reach a large proportion of
eligible patients. These patients were called a maximum of
seven times at different times of the day and messages were
left where possible. These could be individuals who were
not interested in additional follow-up for their fracture,
thus, limiting the generalizability of the findings. In the
future, one way to improve this may be to send patients a
letter informing them about the program before the
coordinator calls. In addition, the loss to follow-up was
greater in among intervention patients. As a result the
‘complete case’ analysis would potentially overestimate the
impact of the intervention since those lost to follow-up in
the intervention probably did not want to be contacted
again if they did not comply with the coordinator’s
suggestions made at baseline. Another potential limita-
tion is the lack of quality control procedures to assess
treatment fidelity. The coordinator was not taped or
observed when delivering the intervention. It was
assumed that treatment fidelity was high given that the
centralized coordinator was a physical therapist with
expertise in osteoporosis management.
Our findings are also limited by the fact that we relied on
self-report data, which may have biased our estimate of
appropriate management since we did not have access to
the actual BMD reports or patient charts. Avalidation study
of DXA results identifies that patients underestimate bone
loss, and although 84% of patients with normal BMD by
Table 3 Primary and secondary outcomes among males and females
by allocation to intervention or control group
Outcome Intervention Control
Males
(n=34; %)
Females
(n=96; %)
Males
(n=44; %)
Females
(n=93; %)
Physician discussed
osteoporosis
76.4 84.2 59.1 52.7
BMD test 50.0 59.4 13.6 24.7
Appropriate
management
29.4 51.0
a 9.1 34.4
a
a Subgroup comparison of males and females within each of
intervention and control group, p<0.05
Osteoporos Int (2012) 23:87–95 93DXA correctly identify their bones as normal, 49% with
‘osteopenia’ and 15% with osteoporosis also state that
their bones are normal [30]. This would overestimate our
findings for appropriate management. Similar to all of the
other post-fracture care randomized trials, we measured
‘process’ outcomes, BMD testing and appropriate man-
agement, and not a clinical endpoint, such as recurrent
fracture. However, receipt of a BMD test and/or use of a
medication for osteoporosis is considered an important
quality of care indicator, used by the majority of health
plans in the USA to measure performance of the health
care system [www.ncqa.org].
In conclusion, we found that a multi-faceted intervention
with a centralized osteoporosis coordinator is effective in
improving osteoporosis care in smaller communities that do
not have access to osteoporosis specialists, but there is still
a care gap. There are number of ways in which this
intervention could be improved. There could be better
advertising of the program. For example, there could be
pamphlets/posters in the waiting room and more impor-
tantly staff in the ED could mention to fracture patients the
link between osteoporosis and fracture and that the hospital
has a special program for fracture patients. Rates of BMD
testing are higher than appropriate management suggesting
that interventions in the future need to address issues with
reporting and interpretation of bone density measurements
and fracture risk in treatment decision making. Treatment
rates might be higher if patients understood their BMD
results better for example this could be achieved with a
standardized report for the family physicians outlining
fracture risk and treatment recommendations and a
patient-specific BMD report. We also need to improve our
efforts to disseminate information about the importance of
osteoporosis in men to health care providers and clarify
treatment recommendations. Finally, in terms of knowledge
translation this intervention is best suited for a universal or
managed care setting.
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